U.S. Medical Marijuana Market Size By Application (Pain Management {Neuropathic Pain, Cancer Pain}, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration, (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Indust

U.S. Medical Marijuana Market Size By Application (Pain Management {Neuropathic Pain, Cancer Pain}, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration, (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Zonal Outlook (Industry Analysis Report, Zone Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030

The U.S. medical marijuana market size is poised to witness substantial growth over the forecast years 2022 to 2030. Increasing government efforts to legalize marijuana for medical purposes has helped authorize product consumption across more than two-thirds of U.S. States. Agencies like the U.S. Food and Drug Administration (FDA) have permitted medical marijuana-based treatment for two rare and severe forms of epilepsy, namely Lennox-Gastaut syndrome and Dravet syndrome.

Growing efforts to determine the efficacy of cannabis-infused medical supplements to aid cancer patients or individuals with other neurological conditions will positively affect the industry outlook. In April 2022, the U.S. House of Representatives passed a bipartisan marijuana research bill, allowing scientists access to marijuana at dispensaries of legal cannabis states. The Marijuana Opportunity Reinvestment & Expungement Act is expected to boost R&D, access, and further development of novel medical marijuana products.

The U.S. medical marijuana market is categorized into the application, route of administration, distribution channel, and region.

With respect to application, the industry is bifurcated into pain management, seizures, anorexia, muscle spasms, and nausea. The market share from the seizures segment exceeded USD 305 million in 2021.

Medical marijuana is widely used to treat seizures, which occur on uncontrolled electrical disturbances in the human brain. Epilepsy is one such seizure-inducing health condition that affects nearly 3.4 million people in the U.S. The rising prevalence of seizures in the U.S. will fuel demand for medical marijuana.

Based on the route of administration, the U.S. medical marijuana market is fragmented into oral, inhalation, and topical. Among these, the market share from the inhalation segment is projected to exhibit over 10% CAGR between 2022-2030. Administration of medical marijuana with the help of inhalers allows the drug to reach target organs and thus requires a lesser dosage. A medical marijuana inhaler delivers accurate quantities of THC and CBD to provide relief from discomfort, and tension.

In terms of distribution channel, the industry is classified into online, and dispensaries. Among these, the online segment accounted for over 39.9% share of the U.S. medical marijuana market in 2021. Rise in the number of online drug stores or pharmacies as a result of growing e-commerce trends enhance access to medical marijuana products.

A large number of manufacturers and suppliers are developing online websites to boost sales and provide timely delivery services, and convenience of shopping to consumers. The availability of a wide variety of products will drive customer engagement across online distribution channels.

West South Central U.S. medical marijuana market size was worth more than USD 1 billion in 2021. West South Central states in the U.S. have witnessed a surge in clinical research for the use of marijuana for medical reasons with government backing. In July 2022, the University of Louisiana Monroe School of Pharmacy secured approval from the Louisiana Senate to conduct cannabis testing and research.